L. Lee KarrasDirector
Mr. Karras joined SK Capital as a Director in 2019 where he provides operational, sales and general management guidance to SK Capital portfolio companies in the healthcare sector.
Most recently, Mr. Karras served as CEO of Halo Pharmaceuticals Inc, an SK Capital Partners portfolio company that was sold to Cambrex Corp in 2018. Prior to Halo, he was President of IBA Molecular North America (also an SK Capital Partners portfolio company) that was sold to Illinois Health and Sciences in 2015. Prior to IBA, Mr. Karras was President and CEO of AAIPharma Services Company where he led the company’s transition from bankruptcy to a successful exit in 2009. Prior to AAI, Lee held various positions at Baxter Healthcare and Cook Medical (Cook and Baxter Pharmaceutical Solutions) where he served as General Manager and helped build the pharmaceutical services start up into a sizable sterile injectable pharma services business.
Lee holds a bachelor’s degree in chemistry from Indiana University Bloomington and a Masters of Science in Environmental Science from Indiana University Bloomington School of Public and Environmental Affairs.